Hospira Carboplatin I.V. Infusion 50mg/5mL single dose vial

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

carboplatin, Quantity: 10 mg/mL

Available from:

Hospira Australia Pty Ltd

INN (International Name):

Carboplatin

Pharmaceutical form:

Injection, intravenous infusion

Composition:

Excipient Ingredients: water for injections

Administration route:

Intravenous Infusion

Units in package:

1 X 5 mL

Class:

Medicine Listed (Export Only)

Prescription type:

(S1) This Schedule is intentionally blank

Therapeutic indications:

Head and neck cancer, small cell lung cancer, testicular cancer, ovarian cancer, uterine cancer, malignant lymphoma, non-small cell lung cancer, breast cancer Used in conjunction with other antineoplastic drugs for the following malignant tumours: Paediatric solid malignant tumours (neuroblastoma/retinoblastoma/ hepatoblastoma/central nervous system neuroblastoma, recurrent or refractory Ewing?s sarcoma family tumours/nephroblastoma)

Product summary:

Visual Identification: Carboplatin Injection is a clear, colourless or pale yellow liquid.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Licence status A

Authorization date:

2013-10-09